Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Naser Ebrahim Daryani"'
Autor:
Mohammad Rahbar, Leila Ganji, Naser Ebrahim Daryani, Mohammad Reza Zali, Parisa Eslami, Mohmmad Hassan Shirazi, Masoud Alebouyeh
Background: Cytolethal distending toxin (Cdt) is one of the bacterial toxins that present in a variety of Gram-negative human pathogens, such as E. coli, Salmonella spp., and Campylobacter spp. CDT composed of three subunits encoded by three adjacent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9940ed3d8c321a29219e060ebdeea2be
https://doi.org/10.21203/rs.3.rs-196235/v1
https://doi.org/10.21203/rs.3.rs-196235/v1
Autor:
Lisa W. Datta, Eun Suk Jung, John D. Rioux, Dermot P.B. McGovern, Naser Ebrahim Daryani, Kyuyoung Song, Yuta Fuyuno, Garima Juyal, Matthias Hübenthal, Ajit Sood, Gabrielle Boucher, Behrooz Z. Alizadeh, Tobias L. Lenz, Byong Duk Ye, Reza Malekzadeh, Soumya Raychaudhuri, Atsushi Takahashi, Siew C. Ng, Frauke Degenhardt, David Ellinghaus, Tom H. Karlsen, Sunny Hwong, Mareike Wendorff, Junji Umeno, Suk-Kyun Yang, Gabriele Mayr, Keiko Yamazaki, Motohiro Esaki, Steven R. Brant, Simonas Juzenas, Rinse K. Weersma, Michiaki Kubo, B.K. Thelma, Esther A. Torres, Eva Ellinghaus, John Schembri, Vandana Midha, Pierre Ellul, David T. Okou, Elisa Rosati, Subra Kugathasan, Jae Hee Cheon, Talin Haritunians, Hesham ElAbd, Myhunghee Hong, Shifteh Abedian, Homayon Vahedi, Stefan Schreiber, Stephen Leslie, Allan Motyer
Publikováno v:
Human Molecular Genetics
Human Molecular Genetics, 30(5), 356-369. Oxford University Press
Human Molecular Genetics, 30(5), 356-369. Oxford University Press
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gut. Genetic association studies have identified the highly variable human leukocyte antigen (HLA) region as the strongest susceptibility locus for IBD and specifically DRB1*01
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38dd65243c5cace197efed557518c64f
Autor:
Vandana Midha, Pierre Ellul, Keiko Yamazaki, John Schembri, Steven R. Brant, B.K. Thelma, Dermot P.B. McGovern, Talin Haritunians, Soumya Raychaudhuri, Naser Ebrahim Daryani, Tom H. Karlsen, Ajit Sood, Suk-Kyun Yang, Mareike Wendorff, Siew C. Ng, Yuta Fuyuno, Rinse K. Weersma, Kyuyoung Song, Motohiro Esaki, Reza Malekzadeh, John D. Rioux, Garima Juyal, Atsushi Takahashi, Byong Duk Ye, Matthias Hübenthal, Gabriele Mayr, Junji Umeno, Frauke Degenhardt, Sunny H. Wong, Eun Suk Jung, Tobias L. Lenz, Simonas Juzenas, Michiaki Kubo, Esther A. Torres, David Ellinghaus, Eva Ellinghaus, Gabrielle Boucher, Behrooz Z. Alizadeh, David T. Okou, Lisa W. Datta, Elisa Rosati, Subra Kugathasan, Jae Hee Cheon, Myhunghee Hong, Stefan Schreiber, Hesham ElAbd, Shifteh Abedian, Homayon Vahedi, Stephen Leslie, Allan Motyer, Andre Franke
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gut. Genetic association studies have identified the highly variable human leukocyte antigen (HLA) region as the strongest susceptibility locus for IBD, and specifically DRB1*0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c0f84d7ace4e0f3283857e98cc09ef2
https://doi.org/10.1101/2020.07.29.20162552
https://doi.org/10.1101/2020.07.29.20162552